Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000989115 | SCV000284608 | benign | Retinoblastoma | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575152 | SCV000674714 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000989115 | SCV001139314 | likely benign | Retinoblastoma | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001557297 | SCV001779034 | likely benign | not provided | 2021-05-18 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28780672, 26332594, 14769601) |
Sema4, |
RCV000575152 | SCV002528283 | benign | Hereditary cancer-predisposing syndrome | 2021-01-04 | criteria provided, single submitter | curation |